Structural Biology of Pathogens and Drug Development
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Microbiology".
Deadline for manuscript submissions: 25 February 2025 | Viewed by 147
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue is dedicated to compiling articles that highlight the most recent advancements in the creation of antiviral and antibacterial medications. Addressing the challenge of emerging infectious diseases and drug-resistant pathogens has been a persistent pursuit in scientific research. The swift progress in structural biology has equipped scientists with the ability to quickly and precisely pinpoint promising antiviral and antibacterial agents. Additionally, structure-based drug discovery and design methodologies have facilitated a reduction in associated costs and an enhancement in the efficiency of the drug development pipeline. In essence, the incorporation of structural biology into drug discovery and design has transformed research approaches within medicinal chemistry and redefined drug screening and optimization techniques. This Special Issue will focus on the latest research in the field of infectious diseases, especially the application of structural biology in drug discovery and design.
Prof. Dr. Litao Sun
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiviral and antibacterial medications
- emerging infectious diseases
- drug-resistant pathogens
- structural biology
- drug discovery and design
- medicinal chemistry
- drug screening
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
